The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent;
Gold Standard for COVID-19 Diagnosis
Wondfo 2019-nCoV/FluA/FluB PCR Assay is a real-time reverse transcription PCR (RT-PCR) assay for rapid, qualitative detection of 2019-nCoV, influenza A and influenza B nucleic acid in oropharyngeal swabs and nasopharyngeal swabs. The test is to be used as an aid in the diagnosis of 2019-nCoV, influenza A and influenza B infection.
Benefits
Flexible
Open system reagents, applicable for major PCR detection system
Whole Process Control
Internal whole-process quality monitoring, from extraction, amplification to detection
Multiple Target Genes
Multiple targets for simultaneous detection
SPECIFICATION
Description
Catalog No.
WE20
Target Gene
2019-nCoV (N and ORF1ab genes)
Influenza A (M gene)
Influenza B (NS gene)